Patchouli alcohol, an essential oil of Pogostemon cablin, exhibits anti-tumorigenic activity in human colorectal cancer cells

International Immunopharmacology

Volumn 16, Issue 2, 2013, Pages 184-190

  Jeong, Jin Boo ^a   Choi, Jieun ^a   Lou, Zhiyuan ^a   Jiang, Xiaojing ^a   Lee, Seong Ho ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

2 c Myc; Colorectal cancer; Histone deacetylase; NF B; Patchouli alcohol

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; ESSENTIAL OIL; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PATCHOULI ALCOHOL; PROTEIN P21; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; COLORECTAL CANCER; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; POGOSTEMON CABLIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLORECTAL NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMIACEAE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-MYC; SESQUITERPENES;

EID: 84877674321     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.04.006     Document Type: Article

References (46)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. G.M.L. Cragg, D.G.I. Kingston, and D.J. Newman Anticancer agents from natural products 2005 Taylor & Francis Boca Raton, Fla.
3. F. Bakkali, S. Averbeck, D. Averbeck, and M. Waomar Biological effects of essential oils - a review Food Chem Toxicol 46 2008 446 475 (Pubitemid 350297552)
4. A. Tahraoui, J. El-Hilaly, Z.H. Israili, and B. Lyoussi Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province) J Ethnopharmacol 110 2007 105 117 (Pubitemid 46217839)
5. J. Gutierrez, C. Barry-Ryan, and R. Bourke The antimicrobial efficacy of plant essential oil combinations and interactions with food ingredients Int J Food Microbiol 124 2008 91 97
6. K. Chaieb, T. Zmantar, R. Ksouri, H. Hajlaoui, K. Mahdouani, and C. Abdelly Antioxidant properties of the essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species Mycoses 50 2007 403 406 (Pubitemid 47260471)
7. V. Manohar, C. Ingram, J. Gray, N.A. Talpur, B.W. Echard, and D. Bagchi Antifungal activities of origanum oil against Candida albicans Mol Cell Biochem 228 2001 111 117 (Pubitemid 34121443)
8. N. Mezzoug, A. Elhadri, A. Dallouh, S. Amkiss, N.S. Skali, and J. Abrini Investigation of the mutagenic and antimutagenic effects of Origanum compactum essential oil and some of its constituents Mutat Res Genet Toxicol Environ Mutagen 629 2007 100 110 (Pubitemid 46656199)
9. M.X. Su, P. Wu, Y.L. Li, and H.Y. Chung Antiproliferative effects of volatile oils from Centipeda minima on human nasopharyngeal cancer CNE cells Nat Prod Commun 5 2010 151 156
10. A. Kumar, F. Malik, S. Bhushan, V.K. Sethi, A.K. Shahi, and J. Kaur An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells Chem Biol Interact 171 2008 332 347
11. M. Verma, S.K. Singh, S. Bhushan, H.C. Pal, S. Kitchlu, and M.K. Koul Induction of mitochondrial-dependent apoptosis by an essential oil from Tanacetum gracile Planta Med 74 2008 515 520 (Pubitemid 351655968)
12. M.R. Loizzo, R. Tundis, F. Menichini, A.M. Saab, G.A. Statti, and F. Menichini Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells Cell Prolif 41 2008 1002 1012
13. A. Calcabrini, A. Stringaro, L. Toccacieli, S. Meschini, M. Marra, and M. Colone Terpinen-4-ol, the main component of Melaleuca alternifolia (Tea tree) oil inhibits the in vitro growth of human melanoma cells J Invest Dermatol 122 2004 349 360 (Pubitemid 38281055)
14. X.W. Huang, L. Bai, F.H. Xu, and Y.J. Wu Inhibitory activities of patchouli alcohol on neurotoxicity of β-amyloid peptide Med J Chin People Liberation Army 24 2008 338 340
15. H. Kiyohara, C. Ichino, Y. Kawamura, T. Nagai, N. Sato, and H. Yamada Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth J Nat Med-Tokyo 66 2012 55 61
16. Y.C. Li, Y.F. Xian, S.P. Ip, Z.R. Su, J.Y. Su, and J.J. He Anti-inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in animal models Fitoterapia 82 8 2011 1295 1301
17. Y.F. Xian, Y.C. Li, S.P. Ip, Z.X. Lin, X.P. Lai, and Z.R. Su Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages Exp Ther Med 2 2011 545 550
18. J.B. Jeong, Y.K. Shin, and S.H. Lee Anti-inflammatory activity of patchouli alcohol in RAW264.7 and HT-29 cells Food Chem Toxicol 55 2013 229 233
19. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32 42
20. X.J. Yang, and E. Seto The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men Nat Rev Mol Cell Biol 9 2008 206 218 (Pubitemid 351301825)
21. M.A. Glozak, and E. Seto Histone deacetylases and cancer Oncogene 26 2007 5420 5432 (Pubitemid 47255924)
22. D.R. Smith, and H.S. Goh Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene Clin Cancer Res 2 1996 1049 1053 (Pubitemid 26198474)
23. G.M. Marshall, S. Gherardi, N. Xu, Z. Neiron, T. Trahair, and C.J. Scarlett Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects Oncogene 29 2010 5957 5968
24. A. Albihn, J.I. Johnsen, and M.A. Henriksson MYC in oncogenesis and as a target for cancer therapies Adv Cancer Res 107 2010 163 224
25. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 2006 769 784 (Pubitemid 44348499)
26. O. Witt, H.E. Deubzer, T. Milde, and I. Oehme HDAC family: what are the cancer relevant targets? Cancer Lett 277 2009 8 21
27. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 2001 7065 7077 (Pubitemid 32916079)
28. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
29. S.B. Gibson, R. Oyer, A.C. Spalding, S.M. Anderson, and G.L. Johnson Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL Mol Cell Biol 20 2000 205 212 (Pubitemid 30002562)
30. N.D. Perkins, and T.D. Gilmore Good cop, bad cop: the different faces of NF-kappaB Cell Death Differ 13 2006 759 772
31. V. Baud, and M. Karin Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls Nat Rev Drug Discov 8 2009 33 40
32. R.L. Beijersbergen, and R. Bernards Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins Biochim Biophys Acta 1287 1996 103 120 (Pubitemid 26189190)
33. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816 (Pubitemid 23346377)
34. C.E. Nesbit, J.M. Tersak, and E.V. Prochownik MYC oncogenes and human neoplastic disease Oncogene 18 1999 3004 3016 (Pubitemid 29276540)
35. B. Amati Integrating Myc and TGF-beta signalling in cell-cycle control Nat Cell Biol 3 2001 112 113
36. C.V. Dang c-Myc target genes involved in cell growth, apoptosis, and metabolism Mol Cell Biol 19 1999 1 11 (Pubitemid 29018404)
37. S. Ogino, K. Nosho, N. Irahara, S. Kure, K. Shima, and Y. Baba A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases Clin Cancer Res 15 2009 4431 4438
38. S. Ogino, K. Nosho, K. Shima, Y. Baba, N. Irahara, and G.J. Kirkner p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis Cancer Epidemiol Biomarkers Prev 18 2009 2513 2521
39. P. Zhu, E. Martin, J. Mengwasser, P. Schlag, K.P. Janssen, and M. Gottlicher Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis Cancer Cell 5 2004 455 463 (Pubitemid 38610247)
40. S. Ropero, E. Ballestar, M. Alaminos, D. Arango, S. Schwartz, and M. Esteller Transforming pathways unleashed by a HDAC2 mutation in human cancer Oncogene 27 2008 4008 4012 (Pubitemid 351913637)
41. H.J. Kim, N. Hawke, and A.S. Baldwin NF-kappa B and IKK as therapeutic targets in cancer Cell Death Differ 13 2006 738 747
42. L.A. Stark, K. Reid, O.J. Sansom, F.V. Din, S. Guichard, and I. Mayer Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer Carcinogenesis 28 2007 968 976 (Pubitemid 47072180)
43. F.V.N. Din, L.A. Stark, and M.G. Dunlop Aspirin-induced nuclear translocation of NF kappa B and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency Br J Cancer 92 2005 1137 1143 (Pubitemid 40546681)
44. L.A. Stark, F.V. Din, R.M. Zwacka, and M.G. Dunlop Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells FASEB J 15 2001 1273 1275
45. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
46. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 396 1998 77 80 (Pubitemid 28520452)